MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z

Back pain in Parkinson’s disease: an underestimated problem

B. Douma, I. Bedoui, M. Elfekih, H. Derbali, A. Riahi, M. Messelmani, M. Mansour, J. Zaouali, R. Mrissa (Sousse, Tunisia)
Backward Fall Protection Garment for patients of PSP and other Parkinsonian Syndromes.

H. Singh, D. Singhal, N. Sawal, A. Beri, S. Kumar, G. Hundal, A. Chawla (Chandigarh, India)
Balance rehabilitation for people with mild to moderate Parkinson’s disease: A scoping review of dual-task training interventions and outcome measures

N. Cakmak, J. Freeman, C. Carroll, A. Logan, L. Bunn (Plymouth, United Kingdom)
Ballistic single-joint arm movements in levodopa-induced dyskinesias in Parkinson´s disease.

V. Gómez-Mayordomo, A. Fernández-Revuelta, A. Baltasar-Corral, M. Fernández-García, E. López-Valdés, R. García-Ramos, F. Alonso-Frech (Madrid, Spain)
Baseline and six months change in cortical perfusion in a mesenchymal stem cell trial for Parkinson’s disease

M. Schiess, J. Suescun, S. Chandra, V. Thyne, T. Ellmore (Houston, USA)
Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson’s disease

SJ. Chung, YJ. Kim, YH. Sohn, PH. Lee (Yongin-Si, Republic of Korea)
BASELINE OLFACTION TESTING IN PARKINSON’S DISEASE PATIENTS IS CORRELATED WITH LONG-TERM DOPAMINERGIC DENERVATION IN STRIATAL SUB-REGIONS: LONGITUDINAL DATA FROM THE PPMI STUDY.

C. Koros, A-M. Simitsi, N. Papagiannakis, A. Prentakis, A. Bougea, D. Papadimitriou, R. Antonelou, I. Pachi, E. Angelopoulou, E. Stanitsa, I. Beratis, S. Papageorgiou, M. Stamelou, X. Trapali, L. Stefanis (Athens, Greece)
Be aware of pitfalls: Bioinformatic analysis of Cas9-targeted Nanopore sequencing of the RFC1 repeat in CANVAS

I. Wohlers, H. Pott, S. Schaake, J. Trinh, H. Busch, K. Lohmann (Lübeck, Germany)
Behavioral effects of stimulated dopamine release and D2-like receptor displacement in Parkinson’s patients with impulse control disorder

S. Lee, M. Aumann, A. Song, K. Hay, P. Diaz, Y. Yan, H. Kang, D. Claassen (Nashville, USA)
Belly Dancer’s Dyskinesia with Systemic Lupus Erythematosus: A Case Report

EAJ. Hutabarat, NA. Santosa (Surakarta, Indonesia)
Benefits of Treatment with OnabotulinumtoxinA in Naive and Non-naive Patients with Cervical Dystonia are Sustained over Time: Preliminary Completer Analysis from CD PROBE

P. Agarwal, M. Schwartz, A. Zuzek, A. Patel (Kirkland, USA)
Benign Progressive Supranuclear Palsy: mild pathology associated with parkinsonism

B. Couto, I. Martinez-Balbuena, S. Lee, N. Visanji, A. Lang, G. Kovacs (Toronto, Canada)
Beta synchronization of the subthalamic nucleus during self-initiated and externally generated movement in parkinsonian patients in OFF and ON states

V. Filyushkina, E. Belova, S. Usova, A. Tomskiy, A. Sedov (Moscow, Russian Federation)
Beta-antagonists and risk of Parkinson’s disease: Meta-analysis of real-world evidence studies

A. Singh, S. Hussain, B. Antony (Hobart, Australia)
Bilateral focused ultrasound thalamotomy for essential tremor (BEST-FUS trial): safety and efficacy proof of principle

C. Iorio-Morin, K. Yamamoto, C. Sarica, A. Zemmar, M. Levesque, S. Brisebois, J. Germann, A. Loh, A. Boutet, G. Elias, P. Azevedo, E. Adam, U. Patel, M. Lenis, S. Kalia, M. Hodaie, A. Fasano, A. Lozano (Sherbrooke, Canada)
BILATERAL SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A PATIENT WITH PARKINSON DISEASE AND INTOLERANCE TO STANDARD ANTIPARKINSONIAN DRUGS – A CASE REPORT

M. Tsalta-Mladenov, V. Dimitrova, M. Moynov, S. Andonova, Y. Enchev (Varna, Bulgaria)
Biofluid Biomarkers in Prodromal Parkinson’s Disease

B. Mollenhauer, L. Chahine, M. Dakna, M. Bartl, A. Siderowf, SJ. Hutten, K. Merchant, K. Marek, D. Galasko (Kassel, Germany)
Biomarker candidates – Peptides identified to be differentially abundant in cerebrospinal fluid of patients with Parkinson´s disease

L. Schilde, B. Serschnitzki, F. Maass, M. Bähr, P. Lingor, C. May, K. Marcus (Bochum, Germany)
Blepharospasm – a network disorder

MC. Posirca, R. Ivan, I. Caloianu, M. Mitrica, CA. Sirbu (Bucharest, Romania)
Blindness analyses in STEADY-PD3: a phase III placebo-controlled double-blind randomized trial of Isradipine as a disease modifying agent in early Parkinson Disease

T. Mestre, S. Eberly, C. Grimes, D. Oakes, T. Simuni (Ottawa, Canada)
Blood-based circulating microRNAs for discriminating between Parkinson’s disease subtypes

MT. Periñán, P. Gómez-Garre, S. Jesús, D. Buiza-Rueda, MV. Jimenez-Jaraba, D. Macías-García, AD. Adarmes-Gómez, P. Mir (Seville, Spain)
Body mass index and incidence of Parkinson’s disease in French women from the E3N cohort study

B. Portugal, F. Artaud, C. Domenighetti, E. Roze, I. Dagaey, M. Canonico, A. Elbaz (Villejuif, France)
Both online and in-person JOBGRIP group training for people with Parkinson’s with paid employment is acceptable and perceived to be valuable

I. Sturkenboom, J. Vanomme-Vanlaarhoven, M. Noordegraaf, B. Bloem (Nijmegen, Netherlands)
Botulinum injections for idiopathic cervical dystonia: a longitudinal study

G. Yahalom, T. Fay-Karmon, V. Livneh, S. Israeli-Korn, L. Ephraty, S. Hassin-Baer (Jerusalem, Israel)
Botulinum Toxin Injections For Movement Disorders During the COVID-19 Pandemic: A Single-Center Experience

B. Dorfman, M. Velickovic, W. Tse (New York, USA)
Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up

C. Borrue, C. Jimeno (Madrid, Spain)
Brain activity of the emotional circuit in Parkinson’s disease patients with freezing of gait

E. Sarasso, F. Agosta, N. Piramide, E. Canu, MA. Volontè, M. Filippi (Milan, Italy)
Brain MRI Cortical Atrophy correlation to clinical onset in Huntington’s Disease

H. Estrada-Rodriguez, JD. Garcia-Romero, MA. Muñuzuri-Camacho, RA. Abundes-Corona, DD. Vásquez Guevara, LM. Gaibor Noboa, A. Cervantes-Arriaga, M. Rodriguez-Violante (Mexico City, Mexico)
Brain MRI morphological changes in different self-reported sleep disturbances in PD patients

X. Ma, W. Su, H. Chen (Beijing, China)
Brain SPECT in Patients with Akinetic-Rigid Syndrome Secondary to Radiotherapy

C. Soldevila-Lozano, J. Mora-Salvadó, MT. Bajén-Lázaro, L. Rodríguez-Bel, L. Fernández-Romero, M. Cortés-Romera (Barcelona, Spain)
Brainstem planimetry in Parkinson’s disease with REM behaviour disorder.

D. Urso, S. Nigro, B. Tafuri, G. Logroscino (Tricase, Italy)
Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD)

L. Ramig, R. Macdonald, P. Jiang, H. Hodges, J. Spielman, O. Reed, E. Nauman, C. Bergey, J. Cattiau (New York, USA)
Building a Global Parkinson’s Genetics Program (GP2): Clinical Cohorts Integration Working Group

J. Joubert, M. Tan, T. Antar, A. Martinez-Carrasco, H. Iwaki, H. Morris, GP2. Genetics Program (London, United Kingdom)
Burden of illness among US Medicare beneficiaries with late-onset Huntington’s disease

J. Ta, S. Reiss Reddy, E. Chang, A. Exuzides, R. Gandhy, G. Yohrling (South San Francisco, USA)

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z